Compare ADMA & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | GVA |
|---|---|---|
| Founded | 2004 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.5B |
| IPO Year | N/A | 1990 |
| Metric | ADMA | GVA |
|---|---|---|
| Price | $19.49 | $118.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $28.50 | ★ $105.00 |
| AVG Volume (30 Days) | ★ 2.8M | 708.5K |
| Earning Date | 11-05-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | ★ 205.35 | 68.53 |
| EPS | 0.86 | ★ 3.67 |
| Revenue | $488,559,000.00 | ★ $4,236,312,000.00 |
| Revenue This Year | $22.19 | $11.29 |
| Revenue Next Year | $24.33 | $10.61 |
| P/E Ratio | ★ $23.22 | $32.04 |
| Revenue Growth | ★ 27.63 | 6.87 |
| 52 Week Low | $13.50 | $69.08 |
| 52 Week High | $25.67 | $118.43 |
| Indicator | ADMA | GVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 76.50 |
| Support Level | $18.33 | $113.18 |
| Resistance Level | $19.94 | $117.12 |
| Average True Range (ATR) | 0.66 | 2.82 |
| MACD | -0.16 | 0.64 |
| Stochastic Oscillator | 56.86 | 95.87 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.